188 related articles for article (PubMed ID: 15332087)
1. An animal model of vascular amyloidosis.
Ghiso J; Wisniewski T
Nat Neurosci; 2004 Sep; 7(9):902-4. PubMed ID: 15332087
[No Abstract] [Full Text] [Related]
2. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
[TBL] [Abstract][Full Text] [Related]
3. One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice.
Le Cudennec C; Faure A; Ly M; Delatour B
Genes Brain Behav; 2008 Feb; 7 Suppl 1():83-91. PubMed ID: 18184372
[TBL] [Abstract][Full Text] [Related]
4. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host.
Meyer-Luehmann M; Coomaraswamy J; Bolmont T; Kaeser S; Schaefer C; Kilger E; Neuenschwander A; Abramowski D; Frey P; Jaton AL; Vigouret JM; Paganetti P; Walsh DM; Mathews PM; Ghiso J; Staufenbiel M; Walker LC; Jucker M
Science; 2006 Sep; 313(5794):1781-4. PubMed ID: 16990547
[TBL] [Abstract][Full Text] [Related]
5. Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice.
Wegiel J; Imaki H; Wang KC; Wegiel J; Rubenstein R
Brain Res; 2004 Oct; 1022(1-2):19-29. PubMed ID: 15353209
[TBL] [Abstract][Full Text] [Related]
6. A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesis.
Soskić V; Klemm M; Proikas-Cezanne T; Schwall GP; Poznanović S; Stegmann W; Groebe K; Zengerling H; Schoepf R; Burnet M; Schrattenholz A
J Proteome Res; 2008 Jun; 7(6):2262-9. PubMed ID: 18465891
[TBL] [Abstract][Full Text] [Related]
7. The effect of amyloidosis-beta and ageing on proliferation of neuronal progenitor cells in APP-transgenic mouse hippocampus and in culture.
Kolecki R; Lafauci G; Rubenstein R; Mazur-Kolecka B; Kaczmarski W; Frackowiak J
Acta Neuropathol; 2008 Oct; 116(4):419-24. PubMed ID: 18483741
[TBL] [Abstract][Full Text] [Related]
8. [What causes Abeta amyloidosis in the brain?].
Matsubara E; Yanagisawa K
No To Shinkei; 2005 Oct; 57(10):829-38. PubMed ID: 16277228
[No Abstract] [Full Text] [Related]
9. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis.
Carro E; Trejo JL; Gerber A; Loetscher H; Torrado J; Metzger F; Torres-Aleman I
Neurobiol Aging; 2006 Sep; 27(9):1250-7. PubMed ID: 16183170
[TBL] [Abstract][Full Text] [Related]
10. The accessible cerebral vascular proteome in a mouse model of cerebral β-amyloidosis.
Roesli C; Fugmann T; Borgia B; Schliemann C; Neri D; Jucker M
J Proteomics; 2011 Apr; 74(4):539-46. PubMed ID: 21262399
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides determine the amyloid pathology of Alzheimer's disease.
Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
[TBL] [Abstract][Full Text] [Related]
12. BACE1 and mutated presenilin-1 differently modulate Abeta40 and Abeta42 levels and cerebral amyloidosis in APPDutch transgenic mice.
Herzig MC; Paganetti P; Staufenbiel M; Jucker M
Neurodegener Dis; 2007; 4(2-3):127-35. PubMed ID: 17596707
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels.
Pacheco-Quinto J; Rodriguez de Turco EB; DeRosa S; Howard A; Cruz-Sanchez F; Sambamurti K; Refolo L; Petanceska S; Pappolla MA
Neurobiol Dis; 2006 Jun; 22(3):651-6. PubMed ID: 16516482
[TBL] [Abstract][Full Text] [Related]
14. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice.
Hope J; Kirby L
Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360
[TBL] [Abstract][Full Text] [Related]
15. Distribution of vascular amyloid in scrapie-affected sheep with different genotypes.
Ligios C; Dexter G; Spiropoulos J; Maestrale C; Carta A; Simmons MM
J Comp Pathol; 2004 Nov; 131(4):271-6. PubMed ID: 15511535
[TBL] [Abstract][Full Text] [Related]
16. Stereological analysis of microvascular parameters in a double transgenic model of Alzheimer's disease.
Lee GD; Aruna JH; Barrett PM; Lei DL; Ingram DK; Mouton PR
Brain Res Bull; 2005 Apr; 65(4):317-22. PubMed ID: 15811597
[TBL] [Abstract][Full Text] [Related]
17. Triple fluorescence labelling of neuronal, glial and vascular markers revealing pathological alterations in various animal models.
Härtig W; Reichenbach A; Voigt C; Boltze J; Bulavina L; Schuhmann MU; Seeger J; Schusser GF; Freytag C; Grosche J
J Chem Neuroanat; 2009 Mar; 37(2):128-38. PubMed ID: 19028564
[TBL] [Abstract][Full Text] [Related]
18. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
19. Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.
Rostagno A; Holton JL; Lashley T; Revesz T; Ghiso J
Cell Mol Life Sci; 2010 Feb; 67(4):581-600. PubMed ID: 19898742
[TBL] [Abstract][Full Text] [Related]
20. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice.
Bernardo A; Harrison FE; McCord M; Zhao J; Bruchey A; Davies SS; Jackson Roberts L; Mathews PM; Matsuoka Y; Ariga T; Yu RK; Thompson R; McDonald MP
Neurobiol Aging; 2009 Nov; 30(11):1777-91. PubMed ID: 18258340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
